Shamburg News · 8-K filed Nov 5, 2026, 5:25 PM EST
Annovis Bio Announces Pricing of Approximately $21.0 Million Public Offering
ANVS · Annovis Bio, Inc.
- Material agreement
- Financing
- Reg FD disclosure
- Materiality: high
On November 5, 2026, Annovis Bio, Inc. entered into an underwriting agreement with Canaccord Genuity LLC for a public offering of 19,000,000 shares of common stock and pre-funded warrants for 2,000,000 shares, with accompanying warrants for up to 21,000,000 shares. The combined offering price per share and accompanying warrant is $1.00, with expected gross proceeds of approximately $21.0 million before discounts and expenses. A director is purchasing 5,000,000 shares and accompanying warrants in the offering, and closing is expected on or about November 6, 2026.
Source: SEC EDGAR, Form 8-K, Items 1.01, 7.01, 9.01, accession 0001104659-26-123467.
Written from the filing by Shamburg Markets. Figures are as reported by the company.